Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diffuse Cutaneous Systemic Sclerosis: early-phase trial registry
2 of 7 indexed Diffuse Cutaneous Systemic Sclerosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Diffuse Cutaneous Systemic Sclerosis: 7 US clinical trials tracked, 2 recruiting.
Diffuse Cutaneous Systemic Sclerosis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Dinesh Khanna, MD, MS, running 1 of these trials.
Enrollment posture brief
Registry condition diffuse-cutaneous-systemic-sclerosis
OPEN 2 | RECR 29% | LATE 0 | EARLY 7 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Diffuse Cutaneous Systemic Sclerosis lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diffuse Cutaneous Systemic Sclerosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diffuse Cutaneous Systemic Sclerosis is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diffuse Cutaneous Systemic Sclerosis trials is spread across many organizations.
Dinesh Khanna, MD, MS accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Diffuse Cutaneous Systemic Sclerosis trials plan to enrol fewer than 100 people.
Median target enrolment is 80 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Diffuse Cutaneous Systemic Sclerosis research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals
NCT06470048
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
CRISPR Therapeutics
NCT06925542
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT05270668
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
David Porter
NCT06152172
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
Century Therapeutics
NCT06255028
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS
NCT02161406
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
Tanabe Pharma America
NCT04440592
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Diffuse Cutaneous Systemic Sclerosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diffuse Cutaneous Systemic Sclerosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diffuse Cutaneous Systemic Sclerosis page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Diffuse Cutaneous Systemic Sclerosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dinesh Khanna, MD, MS sponsors the most Diffuse Cutaneous Systemic Sclerosis trials on record, review their full trial history before evaluating a specific study. See Dinesh Khanna, MD, MS's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diffuse Cutaneous Systemic Sclerosis condition card totals 7 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.